Crossmark

Perspectives for Dopaminergic Therapy in Multiple Sclerosis

Crossref DOI link: https://doi.org/10.1007/s11055-022-01220-8

Published Online: 2022-01-13

Published Print: 2022-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Melnikov, M. V.

Pashenkov, M. V.

Boyko, A. N.
License Information

Text and Data Mining valid from 2022-01-01

Version of Record valid from 2022-01-01
More Information

Article History

Received: 3 June 2020

Accepted: 21 June 2020

First Online: 13 January 2022